Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. (CTXR): 5 pipeline candidates · ~29 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
29.4 months
D/E 1.03 · 0% dilution
Lead: Approved
5 candidates
N/A
N/A
A transparent, data-derived signal for Citius Pharmaceuticals, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$15.1M
Cash
$4.6M
Quarterly Burn
$1.3M
Runway
29.4 mo
Revenue
$1.7M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (5 candidates)
| Drug | Phase |
|---|---|
| Halo-Lido | — |
| LYMPHIR | Approved |
| lymphir was obtained | Approved |
| Mino-Lok | — |
| NoveCite | — |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
35
Total value held
$916K
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 335,476 | $302K |
| geode capital management, llc | 246,158 | $222K |
| vanguard fiduciary trust co | 77,755 | $70K |
| blackrock, inc. | 69,851 | $63K |
| jane street group, llc | 46,423 | $42K |
| northern trust corp | 43,974 | $40K |
| susquehanna international group, llp | 36,838 | $33K |
| citadel advisors llc | 29,100 | $26K |
| state street corp | 23,271 | $21K |
| xtx topco ltd | 21,295 | $19K |
Showing top 10 of 35 institutional holders of Citius Pharmaceuticals, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Citius Pharmaceuticals, Inc.'s pipeline?
Citius Pharmaceuticals, Inc. (CTXR) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Citius Pharmaceuticals, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Citius Pharmaceuticals, Inc. has approximately 29.4 months of cash runway.
What is Citius Pharmaceuticals, Inc.'s market capitalization?
Citius Pharmaceuticals, Inc.'s market capitalization is approximately $15.1M.
Who is the CEO of Citius Pharmaceuticals, Inc.?
Mr. Leonard L. Mazur is the chief executive officer of Citius Pharmaceuticals, Inc. (CTXR).
Get the full picture on Citius Pharmaceuticals, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.